Merck considering purchase of cancer drug maker Seagen – WSJ
(Reuters) – Drugmaker Merck & Co is considering buying cancer-focused biotech company Seagen Inc, the Wall Street Journal reported on Friday, citing people familiar with the matter. Talks have been…